
Aim And Scope
Aim
Cancer science stands at a dynamic intersection of biology, medicine, and technology, with the ultimate goal of improving outcomes for individuals and communities affected by cancer. The International Journal of Cancer Science & Clinical Oncology (IJCSCO) is a key platform for sharing knowledge that pushes this field forward.
Our journal is committed to facilitating the exchange of high-quality, peer-reviewed scientific research on a wide range of oncology topics. This includes, but isn't limited to, Cancer Biology, Clinical Oncology, Translational Research, and Cancer Epidemiology. We provide a platform for rigorous research and scholarly contributions that significantly advance cancer care and prevention.
IJCSCO places a premium on the quality and integrity of the research we publish. Our rigorous peer-review process ensures that all content meets the highest standards of scientific excellence. We are dedicated to a rapid turnaround time for review and publication, which allows for the timely dissemination of valuable research findings to the global scientific community.
By embracing open-access principles, we ensure that published articles are freely available worldwide, promoting unrestricted access to knowledge. This fosters a collaborative environment that encourages further exploration and innovation in all areas of oncology.
In summary, the IJCSCO plays a pivotal role in advancing the frontiers of knowledge in cancer science. Through collaboration, high-quality research, and open access, we strive to make meaningful contributions to the ongoing enhancement of cancer treatment and health outcomes globally.
Scope
• Precision Oncology
• Tumor Microenvironment
• Cancer Immunotherapy
• AI in Cancer Diagnosis & Treatment
• Genomic Medicine & Cancer Genetics
• Liquid Biopsies & Biomarkers
• Nanomedicine for Cancer Therapy
• Epigenetics in Carcinogenesis
• Radiation & Surgical Oncology
• Targeted Drug Delivery
• Clinical Trial Design & Outcomes
• Palliative Care in Oncology
• Cancer Epidemiology & Prevention
• Pharmacogenomics
• Onco-Informatics